Evidence mapPaperPMID 41928451Full record

ArticleCardiovascular research2026

Mass spectrometric proteome profiling using a deep spectral library reveals homogenization of right and left atrial proteomes in persistent atrial fibrillation patients.

Aiste Liutkute, Takiy-Eddine Berrandou, Stefanie Kestel, Moritz Schnelle, Olga Dschun, Hugo Alejandro Amedei, Lisa Neuenroth, Eric Rytkin, Oksana Kyshynska, George Kensah and 13 more

Abstract read
In one paragraph

Article in Cardiovascular research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors.

Aiste LiutkuteInstitute of Pharmacology and Toxicology, University Medical Center Göttingen, Germany.ORCID 0000-0002-8855-4870
Takiy-Eddine BerrandouUniversité Paris Cité, INSERM, PARCC, Paris, France.ORCID 0000-0002-0525-3002
Stefanie KestelInstitute of Pharmacology and Toxicology, University Medical Center Göttingen, Germany.
Moritz SchnelleDepartment of Clinical Chemistry, University Medical Center Göttingen, Germany.ORCID 0000-0001-5134-8347
Olga DschunInstitute of Pathology, University Medical Center  Göttingen, Germany.
Hugo Alejandro AmedeiDepartment of Clinical Chemistry, University Medical Center Göttingen, Germany.
Lisa NeuenrothDepartment of Clinical Chemistry, University Medical Center Göttingen, Germany.ORCID 0000-0002-6137-1695
Eric RytkinDepartment of Biomedical Engineering, Northwestern University, Chicago, IL, USA.ORCID 0000-0003-2511-0655
Oksana KyshynskaDepartment of Thoracic and Cardiovascular Surgery, University Medical Center Göttingen, Germany.
George KensahDepartment of Thoracic and Cardiovascular Surgery, University Medical Center Göttingen, Germany.ORCID 0000-0003-0219-8279
Aschraf El-EssawiDepartment of Thoracic and Cardiovascular Surgery, University Medical Center Göttingen, Germany.ORCID 0000-0002-5583-039X
Ahmad Fawad JebranDepartment of Thoracic and Cardiovascular Surgery, University Medical Center Göttingen, Germany.
Bernhard C DannerDepartment of Thoracic and Cardiovascular Surgery, University Medical Center Göttingen, Germany.
Hassina BarakiDepartment of Thoracic and Cardiovascular Surgery, University Medical Center Göttingen, Germany.ORCID 0000-0003-3938-6484
Ingo KutschkaDepartment of Thoracic and Cardiovascular Surgery, University Medical Center Göttingen, Germany.ORCID 0000-0002-7358-3513
Felix BremmerInstitute of Pathology, University Medical Center  Göttingen, Germany.ORCID 0000-0003-0367-6527
Henning UrlaubCluster of Excellence 'Multiscale Bioimaging: From Molecular Machines to Networks of Excitable Cells' (MBExC), University Medical Center Göttingen, Robert-Koch-Str. 40, 37075 Göttingen, Germany.ORCID 0000-0003-1837-5233
Constanze SchmidtDZHK (German Center for Cardiovascular Research), Partner Site Lower Saxony, Germany.ORCID 0000-0001-5897-237X
Nabila Bouatia-NajiUniversité Paris Cité, INSERM, PARCC, Paris, France.ORCID 0000-0001-5424-2134
Igor R EfimovDepartment of Biomedical Engineering, Northwestern University, Chicago, IL, USA.ORCID 0000-0002-1483-5039
Bianca J J M BrundelDepartment of Physiology, Amsterdam UMC, Vrije Universiteit, Amsterdam Cardiovascular Sciences, Cardiomyopathy and Arrhythmia, Amsterdam, The Netherlands.ORCID 0000-0002-4768-234X
Christof LenzDZHK (German Center for Cardiovascular Research), Partner Site Lower Saxony, Germany.ORCID 0000-0002-0946-8166
Niels VoigtInstitute of Pharmacology and Toxicology, University Medical Center Göttingen, Germany.ORCID 0000-0001-8230-2341

Funding

Collaborative Research Centre 1002Collaborative Research Centre 193793266/SFB1002Deutsche Forschungsgemeinschaft SFB1002Deutsche Forschungsgemeinschaft VO 1568/3-1Deutsche Forschungsgemeinschaft VO 1568/3-2Deutsche Forschungsgemeinschaft VO1568/4-1Deutsche Forschungsgemeinschaft VO1568/6-1German Centre for Cardiovascular Research 81X4300112German Centre for Cardiovascular Research 81X4300115German Centre for Cardiovascular Research DZHK 81X4300102Leducq Foundation
6 · The paper itself

Abstract

aimsPulmonary veins in the left atrium (LA) are well-established as a critical site for the initiation of atrial fibrillation (AF). Emerging evidence suggests that in persistent AF (persAF), AF triggers may extend beyond LA. However, the extent to which AF-associated remodelling involves the right atrium (RA) in persAF remains a subject of debate. To address this, we employed a proteomic approach aiming at investigating AF-associated remodelling in the RA relative to the LA in persAF. METHODS AND

resultsRA and LA samples were obtained from sinus rhythm (SR) patients, patients with persAF undergoing open-heart surgery, and non-failing donor hearts rejected for transplantation. A reference spectral library representing the human cardiac proteome was employed to assess the RA and LA proteomes by data-independent acquisition mass spectrometry. Protein levels were quantified by immunoblotting of human atrial tissue. Plasma levels of NT-proANP and NT-proBNP were measured in SR and persAF patients. Fibrosis levels were quantified in paraffin-embedded sections using Masson-Goldner trichrome staining. A spectral library representing 13 539 human proteins was generated from five anatomical regions of five independent donor hearts. In persAF RA, we observed marked myolysis, excessive extracellular matrix deposition and a prominent similarity to the failing ventricular proteome, all comparable to persAF LA. Although significant proteomic differences were observed between the RA and LA from SR patients, a comparison of RA and LA proteomes in persAF patients revealed proteome homogenization between the two atrial chambers. RA contributes to this homogenization by losing RA-specific markers, while gaining LA-specific markers.

conclusionOur findings suggest that RA undergoes comparable AF-associated remodelling to LA, contributing to atrial proteome unification which represents a hallmark of persAF.

Indexed as

Atrial FibrillationAtrial RemodelingHeart AtriaMass SpectrometryProteomeProteomicsAdultAgedFemaleFibrosisHumansMaleMiddle AgedProteomeAtrial fibrillationDIA-MSProteomeRight atriumSpectral library

Identifiers

PMID41928451
PMCPMC13261532

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.